Neurogene Inc.

IPO

Neurogene - Developing Purpose-built Genetic Medicines

Public · New York, United States · Founded 2018 · $183.5M raised

Headquarters
New York, New York
Employees
51–200
Founded
2018
Business Model
B2B
Total Funding
$183.5M
Last Round
$115.0M Series BDec 2020
Rounds
2
Type
Public

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

Neurogene is a clinical-stage gene therapy company advancing genetic medicines for rare neurological diseases, with its lead program NGN-401 targeting Rett syndrome using a proprietary EXACT technology platform designed to overcome dosage-sensitivity limitations of conventional gene therapy approaches.

Summary

Neurogene Inc. is a Biotech company based in New York, United States, founded in 2018. It has raised $183.5M in total across 2 rounds, most recently a $115.0M Series B round in Dec 2020. Investors include EcoR1 Capital, RTW Investments and Redmile Group.

Tech & App Stack

4 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding & Exit History

Secondary MarketSecondary MarketNov 2024

Sign up to see all 4 events

Funding: Series A through Series B. Amounts, valuations, and investors where available.

Investors

Similar Companies

Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020
BridgeBioIPO

BridgeBio develops treatments for genetic conditions through autonomous condition-focused teams s...

San Francisco Bay Area, United States201–500Biotech, Healthcare
Growth EquityTotal funding$2.7BJul 2026

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Neurogene Inc. on Indexed.vc
<a href="https://indexed.vc/companies/neurogene-inc"><img src="https://indexed.vc/api/badge/company/neurogene-inc" alt="Neurogene Inc. on Indexed.vc" width="260" height="76" /></a>